Soriatane© (Acitretin) - A - Detailing from Skin Therapy Letter

 

Soriatane© (Acitretin)

 

 

  Content:

INDICATIONS

 

 

Psoriasis

  • Approved by the FDA for use in psoriasis in 1997
  • Used in monotherapy to treat generalized pustular, localized pustular and erythrodermic psoriasis
  • More effective at treating severe plaque-type psoriasis when used in combination with other treatments


Off-Label Uses

  • Darierís disease
  • Ichthyosiform erythroderma
  • Lamellar ichthyosis
  • Erythrokeratoderma variabilis
  • Lichen planus
  • Sjogren-Larsson Syndrome
  • Pityriasis rubra pilaris
  • Palmoplantar pustulosis
  • Post-transplantation: to reduce squamous cell carcinomas

Click here for more information on Off-Label Uses


Next:   Patient Profile